NANS

Chr 9AR

N-acetylneuraminate synthase

Also known as: HEL-S-100, SAS, SEMDCG, SEMDG

The NANS protein is a sialic acid synthase that catalyzes the synthesis of phosphorylated forms of sialic acids, including N-acetylneuraminic acid and deaminoneuraminic acid, which are required for brain and skeletal development. Mutations cause spondyloepimetaphyseal dysplasia, Genevieve type, a skeletal dysplasia with autosomal recessive inheritance. This condition affects both the skeletal system and brain development.

OMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismAR1 OMIM phenotype
Clinical SummaryNANS
🧬
Gene-Disease Validity (ClinGen)
spondyloepimetaphyseal dysplasia, Genevieve type · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

📋
ClinVar Variants
51 unique Pathogenic / Likely Pathogenic· 97 VUS of 247 total submissions

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

247 submitted variants in ClinVar

Classification Summary

Pathogenic37
Likely Pathogenic14
VUS97
Likely Benign70
Benign18
Conflicting3
37
Pathogenic
14
Likely Pathogenic
97
VUS
70
Likely Benign
18
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
5
1
31
0
37
Likely Pathogenic
4
5
5
0
14
VUS
1
87
9
0
97
Likely Benign
0
3
23
44
70
Benign
0
2
11
5
18
Conflicting
3
Total10987949239

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NANS · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →